Cinctive Capital Management LP Bio Rad Laboratories, Inc. Transaction History

Cinctive Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $780,620 - $1.07 Million	-1,892 Reduced 44.21%	2,388 $996,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $12.7 Million - $16.3 Million	-27,370 Reduced 86.48%	4,280 $2.12 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $16.6 Million - $23.3 Million	31,650 New	31,650 $17.8 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $3.36 Million - $4.07 Million	-6,150 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $6.74 Million - $8.49 Million	-13,191 Reduced 68.2%	6,150 $3.59 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $2.24 Million - $2.64 Million	4,929 Added 34.2%	19,341 $9.97 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $762,164 - $1.12 Million	2,276 Added 18.75%	14,412 $6.51 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $1.72 Million - $2.19 Million	-5,364 Reduced 30.65%	12,136 $4.25 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $5.6 Million - $6.55 Million	17,500 New	17,500 $6.48 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.